Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Squamous-Cell Non-Small-Cell Lung Cancer × bemarituzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 2 Urinary Bladder Neoplasms 1 Squamous-Cell Non-Small-Cell Lung Cancer 1 Gastrointestinal Neoplasms 1 Gastric or Gastroesophageal Cancer 1 Esophageal Neoplasms 1

Interventions

pembrolizumab 1 bemarituzumab 1 Paclitaxel 1 Docetaxel 1 Carboplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05267470 2025-03-25

FORTITUDE-201

Amgen

Phase 1 Terminated

74 enrolled 22 charts

Squamous-Cell Non-Small-Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡